Concerta is currently protected by a patent that prevents any generic Concerta from being manufactured. The first patent for Concerta is set to expire in 2024.
That's increasingly important these days, as the Concerta authorized-generic (most recently distributed by Patriot) is discontinued and brand Concerta not
Concerta generic being discontinued in January 2024 and discuss treatment options for patients who are unable to access ADHD medications on
Anxiety led to discontinuation of CONCERTA in some patients. It is CONCERTA. Previous Methylphenidate Hydrochloride Daily Dose. Recommended
The Patriot Generic product is being discontinued by the end of January 2024. Patriot is a subsidiary of Janssen who is the maker of brand Concerta. This
Generic Concerta is essentially discontinued so that's not really a shortage. If we had a real OROS system with generic Concerta it would be a
Concerta generic being discontinued in January 2024 and discuss treatment options for patients who are unable to access ADHD medications on
Schedule II drugs, such as Concerta, have a higher risk of being misused than drugs with a higher schedule number. But that brand-name version has been discontinued
If paradoxical aggravation of symptoms or other adverse reactions occur, reduce dosage or, if necessary, discontinue CONCERTA. If improvement is not observed after appropriate dosage adjustment over a one-month period, discontinue CONCERTA.
Comments